Results 201 to 210 of about 1,044,683 (223)

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial

EClinicalMedicine, 2023
Chunyan Lan, Haixi Liang
exaly  

Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer

Nanomedicine: Nanotechnology, Biology, and Medicine, 2023
Yinggang Xu, Jinzhi He, Xiaofeng Huang
exaly  

Albumin-bound paclitaxel approved for MBC in China

Inpharma Weekly, 2008
openaire   +1 more source

Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: A clinical review

Breast, 2011
J Chirgwin
exaly  

Albumin-bound paclitaxel cost effective in MBC

PharmacoEconomics & Outcomes News, 2012
openaire   +1 more source

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

Expert Opinion on Pharmacotherapy, 2012
Valentina Guarneri, Maria Vittoria Dieci, Pierfranco Conte   +2 more
exaly  

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

Gynecologic Oncology, 2013
Mark S Walker, Lee S Schwartzberg, Edward J Stepanski   +2 more
exaly  

Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.

Japanese Journal of Clinical Oncology, 2019
Yuji Minegishi, Teppei Sugano, Yoshinobu Saito   +2 more
exaly  

People also looked at

Frontiers in Pharmacology, 2018
Hong Zhang, Cuiyun Li, Xiaoxue Zhu
exaly  

Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer

Asia-Pacific Journal of Clinical Oncology, 2009
Shiying Yu, Paul Bhar, Zhong-Zhen Guan
exaly